| 标题 |
48P First-line lorlatinib versus sequential second-generation ALK TKI followed by lorlatinib in advanced ALK-positive non-small cell lung cancer: A real-world cohort study |
| 网址 | |
| DOI | |
| 其它 |
期刊:ESMO Open 作者:Y. Xu; R. Song; D. Liu; X. li 出版日期:2026-04-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)